Research Areas‎ > ‎

Ischaemic cardiomyopathy

Ischaemic cardiomyopathy accounts for 7.4% of mortality in Portugal. A large proportion of patients die of acute myocardial infarction complications such as lethal arrhythmia and acute heart failure. This is an enormous medical and social burden since these are mostly active and previously healthy adults. Almost an equal proportion of patients, however, face a long-life of chronic medication and a substantial part progresses to full-blown heart failure. Remarkable advances have been made in acute myocardial infarction therapy. 

Large risk factor prevention campaigns have reduced its incidence but a huge step is missing. Since diagnosis relies on cardiac catheterization, an invasive procedure, screening is not an option. 

>One of our main goals is to make coronary artery disease screening possible at least in high-risk patient subgroups by applying recent advances in cardiac imaging.